Resolution of hordeolum between 8 and 30 days after diagnosis, or that closest to 14 days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
Participant‐reported pain intensity VAS (0‐10, lower score = less pain) · adults with neuropathic pain
1 finding from 1 review
Relief of pain · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants experiencing any serious adverse events · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
At least 50% reduction in pain · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants experiencing any serious adverse events · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life SF‐36 bodily pain score (0‐100, lower score = more disability) · adults with neuropathic pain
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relief of pain · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants experiencing any serious adverse events · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · Patients with idiopathic dysgeusia and hypogeusia
1 finding from 1 review
Adverse events · Patients with idiopathic dysgeusia and hypogeusia
The review found no eligible studies for this question.
1 finding from 1 review
Headache (frequency) · people with episodic migraine
2 findings from 1 review
Number of participants reporting an adverse event · people with episodic migraine
Acupuncture showed no clear difference in number of participants reporting adverse effects compared with sham interventions (high certainty).
1 finding from 1 review
Headache (frequency) · people with episodic migraine
2 findings from 1 review
Response · people with episodic migraine
Acupuncture probably leads to higher response compared with prophylactic drugs (moderate certainty).
2 findings from 1 review
Adverse effects (drop‐outs due to adverse effects4) · people with episodic migraine
Acupuncture probably leads to lower number of participants dropping out due to adverse effects compared with prophylactic drugs (moderate certainty).
1 finding from 1 review